BW-858C

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBW-858C
Drug Alias NameBW-858C
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionArachidonate 5-lipoxygenase inhibitors
TargetsArachidonate 5-lipoxygenase
Therapy Area/IndicationsInflammationAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesBurroughs Wellcome
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBurroughs Wellcome
Active IndicationsN/A
Inactive IndicationsInflammationAsthma

Other Information

ATC CodeN/A
Related LinksN/A